US Patent 11291708 Human-derived recombinant FSH for controlled ovarian stimulation
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Joan-Carles Arce0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Apr, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
Article (+97 characters)
US Patent 11291708 Human-derived recombinant FSH for controlled ovarian stimulation
Article
Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.
Infobox
Is a
Patent jurisdiction
Patent number
11291708
Date of patent
April 5, 2022
Patent application number
16851260
Date Filed
April 17, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11291708 Human-derived recombinant FSH for controlled ovarian stimulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.